Results 21 to 30 of about 1,913,070 (304)

Role of ofatumumab in treatment of chronic lymphocytic leukemia [PDF]

open access: yes, 2011
Marays Veliz, Javier Pinilla-IbarzH Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAAbstract: The management of chronic lymphocytic leukemia (CLL) has dramatically improved in the past decade with the addition of anti-CD20 monoclonal ...
Pinilla-Ibarz J   +3 more
core   +1 more source

The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.

open access: yesPLoS ONE, 2021
Flow cytometry immunophenotyping has an essential role in distinguishing chronic lymphocytic leukemia from other B-chronic lymphoproliferative disorders. Recently, CD200 is considered as a relatively consistent marker in chronic lymphocytic leukemia.
Sana Dlawar Jalal
doaj   +1 more source

Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia

open access: yesHaematologica, 2018
Chronic lymphocytic leukemia is a disease with up-regulated expression of the transmembrane tyrosine-protein kinase ROR1, a member of the Wnt/planar cell polarity pathway. In this study, we identified COBLL1 as a novel interaction partner of ROR1. COBLL1
Hana Plešingerová   +12 more
doaj   +1 more source

Expressió de ZAP-70 en linfòcits B normals i síndromes limfoproliferatives B [PDF]

open access: yes, 2006
[cat] La Leucèmia Limfàtica Crònica (LLC), la més freqüent de les leucèmies en el món occidental, és una malaltia produïda per la proliferació i cúmul de limfòcits B madurs, actualment incurable.
Crespo Maull, Marta
core   +6 more sources

Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study

open access: yesFrontiers in Hematology
BackgroundDisease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.MethodsThis cross-sectional study used the validated Hematological Malignancy
Sam Salek   +12 more
doaj   +1 more source

Leukemia cutis in a patient with chronic lymphocytic leukemia presenting as bilateral helical nodules

open access: yesSAGE Open Medical Case Reports, 2016
Chronic lymphocytic leukemia, the most common adult leukemia worldwide, is considered an indolent but incurable non-Hodgkin lymphoma. Leukemia cutis is an uncommon manifestation of chronic lymphocytic leukemia.
Ali Raufi   +4 more
doaj   +1 more source

Chronic lymphocytic leukemia relapse presenting as acute otitis media with facial palsy

open access: yesEgyptian Journal of Ear, Nose, Throat and Allied Sciences, 2015
Objective: To describe a case of chronic lymphocytic leukemia relapses presenting as bilateral acute otitis media with left facial paralysis. Methods: Case report and review of the literature. Introduction: Chronic lymphocytic leukemia is the most common
Mai Nasser   +2 more
doaj   +1 more source

Cyclosporine A therapy of chronic lymphoblastic leukemia‐related pancytopenia: A case report

open access: yesClinical Case Reports, 2022
To explore the clinical characteristics, diagnosis, and treatment of chronic lymphocytic leukemia with secondary pancytopenia. Here, a case of pancytopenia secondary to chronic lymphocytic leukemia is reported.
Mengying Wang   +9 more
doaj   +1 more source

Chronic lymphocytic leukemia

open access: yesAnnals of Oncology, 2010
The management of chronic lymphocytic leukemia (CLL) is currently undergoing a profound change. First, several new drugs have been approved (fludarabine, bendamustine and two monoclonal antibodies, alemtuzumab and rituximab). In addition, novel monoclonal antibodies targeting CD20, CD23, CD37 or CD40, as well as drugs designed to interfere with central
Michael, Hallek, Natali, Pflug
openaire   +2 more sources

Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia

open access: yesHaematologica, 2016
Abroad array of conditions can lead to neurological symptoms in chronic lymphocytic leukemia patients and distinguishing between clinically significant involvement of the central nervous system by chronic lymphocytic leukemia and symptoms due to other ...
Paolo Strati   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy